Functions of cell surface heparan sulfate proteoglycans M Bernfield, M Götte, PW Park, O Reizes, ML Fitzgerald, J Lincecum, ... Annual review of biochemistry 68 (1), 729-777, 1999 | 3402 | 1999 |
The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages L Schaefer, A Babelova, E Kiss, HJ Hausser, M Baliova, M Krzyzankova, ... The Journal of clinical investigation 115 (8), 2223-2233, 2005 | 991 | 2005 |
The pathogenesis of endometriosis: molecular and cell biology insights AS Laganà, S Garzon, M Götte, P Viganò, M Franchi, F Ghezzi, DC Martin International journal of molecular sciences 20 (22), 5615, 2019 | 461 | 2019 |
Syndecans in inflammation M Götte The FASEB Journal 17 (6), 575-591, 2003 | 441 | 2003 |
Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective M Gotte, GW Yip Cancer research 66 (21), 10233-10237, 2006 | 436 | 2006 |
Therapeutic value of glycosaminoglycans in cancer GW Yip, M Smollich, M Gotte Molecular cancer therapeutics 5 (9), 2139-2148, 2006 | 329 | 2006 |
Heparan sulfate structure in mice with genetically modified heparan sulfate production J Ledin, W Staatz, JP Li, M Götte, S Selleck, L Kjellén, D Spillmann Journal of Biological Chemistry 279 (41), 42732-42741, 2004 | 315 | 2004 |
Vesicular transport: how many Ypt/Rab-GTPases make a eukaryotic cell? T Lazar, M Götte, D Gallwitz Trends in biochemical sciences 22 (12), 468-472, 1997 | 307 | 1997 |
miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness M Götte, C Mohr, CY Koo, C Stock, AK Vaske, M Viola, SA Ibrahim, ... Oncogene 29 (50), 6569-6580, 2010 | 265 | 2010 |
Increased expression of the adult stem cell marker Musashi‐1 in endometriosis and endometrial carcinoma M Götte, M Wolf, A Staebler, O Buchweitz, R Kelsch, AN Schüring, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008 | 245 | 2008 |
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling … SA Ibrahim, R Gadalla, EA El-Ghonaimy, O Samir, HT Mohamed, ... Molecular cancer 16, 1-19, 2017 | 224 | 2017 |
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression V Nikolova, CY Koo, SA Ibrahim, Z Wang, D Spillmann, R Dreier, ... Carcinogenesis 30 (3), 397-407, 2009 | 213 | 2009 |
Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer E Karousou, S Misra, S Ghatak, K Dobra, M Götte, D Vigetti, A Passi, ... Matrix Biology 59, 3-22, 2017 | 202 | 2017 |
Flow cytometry in cancer stem cell analysis and separation B Greve, R Kelsch, K Spaniol, HT Eich, M Götte Cytometry Part A 81 (4), 284-293, 2012 | 196 | 2012 |
Targeting of syndecan‐1 by microRNA miR‐10b promotes breast cancer cell motility and invasiveness via a Rho‐GTPase‐ and E‐cadherin‐dependent mechanism SA Ibrahim, GW Yip, C Stock, JW Pan, C Neubauer, M Poeter, D Pupjalis, ... International journal of cancer 131 (6), E884-E896, 2012 | 179 | 2012 |
Role of syndecan-1 in leukocyte–endothelial interactions in the ocular vasculature M Götte, AM Joussen, C Klein, P Andre, DD Wagner, MT Hinkes, ... Investigative ophthalmology & visual science 43 (4), 1135-1141, 2002 | 177 | 2002 |
Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer I Radke, M Götte, C Kersting, B Mattsson, L Kiesel, P Wülfing British journal of cancer 95 (3), 347-354, 2006 | 170 | 2006 |
Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction D Vanhoutte, MWM Schellings, M Götte, M Swinnen, V Herias, MK Wild, ... Circulation 115 (4), 475-482, 2007 | 166 | 2007 |
Characterization of endometrial mesenchymal stem-like cells obtained by endometrial biopsy during routine diagnostics AN Schüring, N Schulte, R Kelsch, A Röpke, L Kiesel, M Götte Fertility and sterility 95 (1), 423-426, 2011 | 163 | 2011 |
Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers–Danlos syndrome patient carrying the … DG Seidler, M Faiyaz-Ul-Haque, U Hansen, GW Yip, SHE Zaidi, AS Teebi, ... Journal of molecular medicine 84, 583-594, 2006 | 136 | 2006 |